SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Glenn D. Rudolph who wrote (427)7/7/1998 9:56:00 AM
From: Larry Liebman  Read Replies (2) of 1154
 
Lehman has been critical of GENE for not developing products internally, for simply licensing their research for royalties. Last 2 releases indicate a change of heart and desire to capture a greater return by forming partnerships. Company looks cheap to me as many other genomic/combinatorial companies do, e.g. ARQL, PCOP, MYGN, etc. When Amazon is valued at $7 billion dollars, I have to believe that companies like GENE will ultimately be "rediscovered".
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News